Tazemetostat tablets 200mg/tablet, 56 tablets/box

Medication Safety Tips

Use this product according to its instructions, medical advice, and your health needs. Shipping is arranged after payment once the order meets dispatch requirements.

Contraindications

Warnings and Precautions
• Secondary malignancies: LuciTaze increases the risk of secondary malignancies, including T-cell lymphoblastic lymphoma, myelodysplastic syndrome, and acute myeloid leukemia. Long-term monitoring of patients for secondary malignancies.
• Embryo-fetal toxicity: May cause harm to the fetus. Patients are advised to be aware of potential risks to the fetus and to use effective non-hormonal contraceptives.

Medication risks

Adverse Reactions
• The most common adverse reactions (≥ 20%) in patients with epithelioid sarcoma are pain, fatigue, nausea, decreased appetite, vomiting, and constipation.
• The most common (≥ 20%) adverse reactions in patients with follicular lymphoma are fatigue, upper respiratory tract infections, musculoskeletal pain, nausea, and abdominal pain.